跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法 打開新的分頁/視窗

Elsevier
與我們共同出版

Future of Autoimmunity Research

Aim & scope

Future of autoimmunity research is a major new suite of books in autoimmunity, which cover both basic and clinical research. The series seeks to discuss and provide foundational content from bench to bedside in autoimmune diseases

The Series’ goal is to enhance knowledge, and present update on hot topics in the field of autoimmunity; specifically, the series aims to translate results and recent findings of studies into clinical practice.

Written and edited by leading international scientists, the series is primarily intended for researchers, clinicians, and students in autoimmune diseases at the graduate level and above, including those working in academic, corporate, or non-profit settings. Its ethics mission is to enable global benefit sharing of advances in the field of autoimmunity through the publication of foundational, consensus building content.

The Future of autoimmunity research series seeks to provide wide coverage across areas of autoimmunity. Possible subject areas covered by Series Volumes include: Autoimmune diseases; COVID and Autoimmunity, Post COVID syndrome; Autoimmune pancreatitis Controversies in Autoimmunity.

Sample cover of Future of Autoimmunity Research

Audience

Researchers, clinicians, and students in the field of immunology at the graduate level and above, including those working in academic, corporate, or non-profit settings.

Secondary Markets

Immunologists, clinical immunologists and allergists, rheumatologists, haematologists and oncologists, and paediatricians

Series Editor

Image of Yehuda Shoenfeld

YS

Yehuda Shoenfeld

Founder & Head

Tel-Aviv University, Department of Medicine, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 5265601, Israel

繼續閱讀 Yehuda Shoenfeld